Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer.
Kato T, Kudo T, Kagawa Y, Murata K, Ota H, Noura S, Hasegawa J, Tamagawa H, Ohta K, Ikenaga M, Miyazaki S, Komori T, Uemura M, Nishimura J, Hata T, Matsuda C, Satoh T, Mizushima T, Ohno Y, Yamamoto H, Doki Y, Eguchi H.
Kato T, et al. Among authors: komori t.
Sci Rep. 2023 Feb 9;13(1):2331. doi: 10.1038/s41598-022-24057-0.
Sci Rep. 2023.
PMID: 36759648
Free PMC article.
Clinical Trial.